CODEX DNA INC (DNAY) Stock Price, Quote, News and Overview
NASDAQ:DNAY - Nasdaq - US1920031010 - Common Stock - Currency: USD
DNAY Quote, Performance and Key Statistics
NASDAQ:DNAY (1/3/2023, 8:00:01 PM)
1.3
+0.1 (+8.33%)
The current stock price of DNAY is 1.3 USD. In the past month the price decreased by -5.8%. In the past year, price decreased by -86.13%.
DNAY Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 19.48 | 161.06B | ||
| DHR | DANAHER CORP | 26.38 | 140.59B | ||
| A | AGILENT TECHNOLOGIES INC | 20.15 | 30.51B | ||
| IQV | IQVIA HOLDINGS INC | 13.53 | 26.57B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 26.12 | 22.40B | ||
| WAT | WATERS CORP | 28.7 | 20.27B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.72 | 15.22B | ||
| ILMN | ILLUMINA INC | 31.68 | 12.28B | ||
| ICLR | ICON PLC | 10.42 | 12.05B | ||
| RVTY | REVVITY INC | 19.41 | 11.43B | ||
| AVTR | AVANTOR INC | 15.5 | 10.56B | ||
| QGEN | QIAGEN N.V. | 19.48 | 9.31B |
Related stock screener links
About DNAY
Company Profile
Codex DNA, Inc. engages in research and development of genomic tools for biomedical and industrial applications. The company is headquartered in San Diego, California and currently employs 212 full-time employees. The company went IPO on 2021-06-18. Its synthetic biology solution addresses bottlenecks across the multi-step process of building DNA and mRNA, as well as the limitations of existing solutions that prevent the building of DNA and mRNA at a useable scale. Its BioXp system is an end-to-end automated workstation. The firm's products include BioXp systems, including BioXp 3250 system, BioXp kits for generating a range of synthetic DNA and mRNA, and benchtop reagents that complement the automated synthetic biology workflow applications and workflow solutions. The company has launched eight BioXp kits, three benchtop reagent kits, and various other synthetic biology products, including 14 SARS-CoV-2 full-length genomes and RNA controls, as well as its Vmax X2 cells. The company has placed approximately 200 BioXp systems globally.
Company Info
CODEX DNA INC
9535 Waples Street, Suite 100
San Diego CALIFORNIA US
CEO: Todd R. Nelson
Employees: 212
Company Website: https://codexdna.com/
Phone: 18582284115.0
CODEX DNA INC / DNAY FAQ
What is the stock price of CODEX DNA INC today?
The current stock price of DNAY is 1.3 USD. The price increased by 8.33% in the last trading session.
What is the ticker symbol for CODEX DNA INC stock?
The exchange symbol of CODEX DNA INC is DNAY and it is listed on the Nasdaq exchange.
On which exchange is DNAY stock listed?
DNAY stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for CODEX DNA INC stock?
9 analysts have analysed DNAY and the average price target is 6.63 USD. This implies a price increase of 410% is expected in the next year compared to the current price of 1.3. Check the CODEX DNA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CODEX DNA INC worth?
CODEX DNA INC (DNAY) has a market capitalization of 38.38M USD. This makes DNAY a Nano Cap stock.
How many employees does CODEX DNA INC have?
CODEX DNA INC (DNAY) currently has 212 employees.
What are the support and resistance levels for CODEX DNA INC (DNAY) stock?
CODEX DNA INC (DNAY) has a support level at 1.13 and a resistance level at 1.5. Check the full technical report for a detailed analysis of DNAY support and resistance levels.
Is CODEX DNA INC (DNAY) expected to grow?
The Revenue of CODEX DNA INC (DNAY) is expected to grow by 106.09% in the next year. Check the estimates tab for more information on the DNAY EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy CODEX DNA INC (DNAY) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of DNAY, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of DNAY, evaluating the profitability, health, valuation and growth aspects
- CODEX DNA INC (DNAY) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CODEX DNA INC (DNAY) Sales and EPS estimates to see what analysts future expectations are.
- CODEX DNA INC (DNAY) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CODEX DNA INC (DNAY) Insider and Institutional Ownership to learn about the owners and their transactions.
- CODEX DNA INC (DNAY) Stock Chart to make your own analysis
- CODEX DNA INC (DNAY) Latest news and press-releases to stay up to date.
Does CODEX DNA INC (DNAY) stock pay dividends?
DNAY does not pay a dividend.
What is the Price/Earnings (PE) ratio of CODEX DNA INC (DNAY)?
CODEX DNA INC (DNAY) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.8).
DNAY Technical Analysis
DNAY Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to DNAY. Both the profitability and financial health of DNAY have multiple concerns.
DNAY Financial Highlights
Over the last trailing twelve months DNAY reported a non-GAAP Earnings per Share(EPS) of -1.8. The EPS decreased by -63.94% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.37 |
DNAY Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to DNAY. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of -6.4% and a revenue growth 106.09% for DNAY